A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes
Diabetes Care · 01.09.2026 · 49 (9) · 1700-1704
DOI: 10.2337/dc26-0659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 01.07.2026. Verfasst von Kirk R Hohsfield und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Colorado School of Public Health, University of Colorado-Anschutz, Aurora, CO. Hauptthemen laut MEDLINE: Autoimmunity, HLA Antigens, Diabetes Mellitus, Type 1, Islets of Langerhans. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institute of Environmental Health Sciences (NIEHS).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVE We investigated islet autoimmunity (IA) incidence trends among Colorado children born 1993–2010 in Diabetes Autoimmunity Study in the Young (DAISY) and The Environmental Determinants of Diabetes in the Young (TEDDY) and whether HLA genotype or early-life environmental exposures contributed to observed increases. RESEARCH DESIGN AND METHODS We analyzed the risk of IA among 2,734 Colorado children representing three birth cohorts (BCs): BC1 (1993–1998), BC2 (1999-August 2004), and BC3 (September 2004–2010). Cox models evaluated IA by BC, with time-varying coefficients, BC-HLA interaction, and stratification by type 1 diabetes family history. Mediation analyses examined age at gluten introduction, weight-for-age Z-score, and maternal smoking. RESULTS IA increased across BC1–BC3 (7.0%, 10.7%, and 12.7%). At age 1 year, moderate-risk HLA participants in BC2 and BC3 had, respectively, 2.57 and 6.19 times the IA risk of BC1. By age 5 years, effects attenuated. No selected environmental exposures mediated the increased incidence. CONCLUSIONS IA increased among Colorado children born 1993–2010, with the strongest effects among moderate-risk HLA genotypes in later BCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Colorado School of Public Health, University of Colorado-Anschutz, Aurora, CO.
- Department of Biomedical Informatics, School of Medicine, University of Colorado-Anschutz, Aurora, CO.
- Barbara Davis Center for Diabetes, School of Medicine, University of Colorado-Anschutz, Aurora, CO.
- Department of Kinesiology, Nutrition, and Dietetics, University of Northern Colorado, Greeley, CO.
- Department of Orthopedics, School of Medicine, University of Colorado-Anschutz, Aurora, CO.
ORCID-Profile: Kirk R Hohsfield, Andrea K Steck, Teresa Buckner, Randi K Johnson, Patrick M Carry, Brigitte Frohnert, Marian Rewers, Jill M Norris
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institute of Environmental Health Sciences (NIEHS)
- NCATS NIH HHS
- NLM NIH HHS
- National Institute of Allergy and Infectious Diseases
- Breakthrough T1D (formerly JDRF)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Zitieren
APA
Hohsfield, K. R., Dong, F., Waugh, K., Steck, A. K., Buckner, T., Johnson, R. K., Carry, P. M., Frohnert, B., Rewers, M., & Norris, J. M. (2026). A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes. Diabetes Care, 49(9), 1700-1704. https://doi.org/10.2337/dc26-0659
Vancouver
Hohsfield KR, Dong F, Waugh K, Steck AK, Buckner T, Johnson RK, et al. A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes. Diabetes Care. 2026;49(9):1700-1704. doi:10.2337/dc26-0659
BibTeX
@article{Hohsfield2026,
author = {Hohsfield, Kirk R and Dong, Fran and Waugh, Kathleen and Steck, Andrea K and Buckner, Teresa and Johnson, Randi K and Carry, Patrick M and Frohnert, Brigitte and Rewers, Marian and Norris, Jill M},
title = {A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {9},
pages = {1700--1704},
doi = {10.2337/dc26-0659}
}
EUVIMED